每经记者|章光日 每经编辑|何小桃 吴永久 1月30日早上，新诺威（SZ300765，市值546亿元）迎来新任总经理和新任董事会秘书，二人皆为"90后"。不过，资本市场对此反应并不友好，新诺威早 盘股价最大跌幅一度达到18%。而不久前，新诺威还发布了2025年年度业绩预亏公告，净利润较2024年同期下降416%至575%。 新任总经理和董秘皆为"90后" 1月30日，新诺威发布关于变更公司总经理、董事会秘书及证券事务代表的公告。该公告显示，姚兵申请辞去公司总经理职务，戴龙申请辞去公司董事会 秘书及证券事务代表职务，与此同时，公司董事会同意聘任戴龙担任公司总经理，同意聘任徐雯担任公司董事会秘书及证券事务代表。 而新诺威新任总经理戴龙和新任董事会秘书皆为"90后"。 戴龙1992年6月出生，本科学历，2016年12月加入新诺威，历任公司财务经理、证券事务代表、董事会秘书。目前，戴龙还担任新诺威的董事和财务总 监。新诺威2024年年报显示，尽管身兼数职，但戴龙2024年从公司获得的税前报酬总额仅为22.32万元。 徐雯1990年4月出生，硕士学历，从2024年5月开始担任新诺威的董事。不过，新诺威2024年年报显示 ...

Group 1 - New CEO and Secretary appointed at XinNuoWei, both born in the 1990s, leading to a negative market reaction with a stock price drop of up to 18% [1][10] - The company announced a significant expected net profit loss for 2025, projecting a decline of 416% to 575% compared to 2024 [1][12] - The new CEO, Dai Long, has been with the company since 2016 and previously held multiple roles, while the new Secretary, Xu Wen, has a master's degree and will also serve as a board member [2][7] Group 2 - XinNuoWei's main business focuses on biopharmaceuticals and functional foods, with recent developments in ADC, mRNA vaccines, and antibody drugs [12] - The projected net profit for 2025 is expected to be between -1.7 billion to -2.55 billion, marking a significant decline from a profit of 537.26 million in 2024 [12][13] - The decline in performance is attributed to increased R&D expenses, the acquisition of a controlling stake in a subsidiary, and reduced profit margins in the functional raw materials segment [14]

Core Viewpoint - Newnow (300765) has appointed a new general manager and board secretary, both born in the 1990s, but the market reacted negatively, with the stock price dropping by up to 18% in early trading. The company also announced a significant expected net profit decline for 2025, with a decrease of 416% to 575% compared to the same period in 2024 [1]. Group 1 - The new general manager, Dai Long, born in June 1992, has a bachelor's degree and joined Newnow in December 2016, holding multiple roles including financial manager, securities affairs representative, and board secretary [1]. - Despite holding several positions, Dai Long's pre-tax compensation for 2024 was only 223,200 yuan [1]. - Newnow's main business focuses on the research, production, and sales of biopharmaceuticals and functional foods and raw materials, with a focus on cutting-edge areas such as ADC, mRNA vaccines, and antibody drugs [1].

Core Viewpoint - Newnow's stock price dropped significantly following the announcement of new management, with a maximum decline of 18% on January 30, 2024, and a closing drop of 15.72%, resulting in a market capitalization of approximately 54.6 billion yuan [1][8]. Management Changes - Newnow appointed Dai Long as the new General Manager and Xu Wen as the new Secretary of the Board, both of whom are in their 30s [1][6]. - Former General Manager Yao Bing, who was born in May 1977, will continue to serve as the Chairman of the Board after stepping down [4]. - Dai Long, born in June 1992, has held various positions within the company since December 2016 and received a pre-tax salary of 223,200 yuan in 2024 [6][7]. - Xu Wen, born in April 1990, has a master's degree and received no salary from the company in 2024, although she earned compensation from related parties [6][7]. Financial Performance - Newnow's 2025 performance forecast indicates a net loss of 170 million to 255 million yuan, representing a decline of 416% to 575% compared to the same period in 2024 [9][10]. - The company also anticipates a non-recurring net loss of 210 million to 315 million yuan, a decrease of 596% to 844% from 2024 [9][10]. - The decline in performance is attributed to increased R&D expenses for several in-development products, the acquisition of minority stakes in a subsidiary, and reduced profit margins in the functional raw materials business [10]. Business Overview - Newnow's main business focuses on the research, production, and sales of biopharmaceuticals and functional foods, including areas such as ADC, mRNA vaccines, and antibody drugs [8]. - The company has experienced a significant decline in net profits over the past three years, with figures of 726 million yuan in 2022, 434 million yuan in 2023, and 53.726 million yuan in 2024 [10].

Core Viewpoint - Ningbo Suobao Protein Technology Co., Ltd. reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong growth in the soybean protein market driven by rising consumer demand for health and safety in food products [1][2]. Group 1: Financial Performance - The company achieved operating revenue of 1.24 billion yuan, a year-on-year increase of 7.37% [1] - Net profit attributable to shareholders reached 147 million yuan, reflecting a substantial year-on-year growth of 60.00% [1] - In Q3 alone, operating revenue was 466 million yuan, up 21.75% year-on-year, while net profit for the quarter was 49.26 million yuan, marking a remarkable increase of 135.87% [1] Group 2: Business Operations - Suobao Protein specializes in the research, production, and sales of non-GMO soybean protein products, having established a comprehensive deep processing industry chain for non-GMO soybeans [1] - The main products include soybean isolate protein, soybean concentrate protein, textured protein, soybean dietary fiber, and non-GMO soybean oil [1] - The company is actively expanding its international market presence while consolidating its domestic market, enhancing brand recognition and influence [2] Group 3: Industry Trends - There is a growing consumer focus on environmental and health issues, leading to increased demand for organic, green, functional, and health foods globally [1] - Soybean protein is widely used in various sectors, including plant-based meat, meat products, snacks, health products, nutritional supplements, pet food, and bio-fermentation, indicating a broad market development potential [1]

Core Viewpoint - Nestlé plans to lay off approximately 16,000 employees globally over the next two years, primarily targeting white-collar professionals, as part of a strategy to reduce costs and adapt to changing market conditions [5][6][7]. Group 1: Layoff Strategy - The layoffs will save the company 1 billion Swiss francs annually, doubling the previous target of 500 million Swiss francs, with a one-time restructuring cost expected to be twice the annual savings [6]. - The CEO emphasized the need for faster adaptation to market changes, indicating that the company must take difficult but necessary steps to reduce workforce [6][7]. - The majority of the layoffs (75%) will affect cross-functional and cross-regional white-collar workers rather than frontline employees [6]. Group 2: Digital Transformation - Nestlé is implementing a "digital twin" strategy to centralize demand forecasting, promotional scheduling, and SKU profitability calculations into a unified cloud-based data model, allowing AI to provide replenishment and pricing suggestions [6][8]. - This digital transformation aims to streamline operations, reducing the time required for promotional planning from two weeks to 30 minutes, with a low error rate [6][8]. Group 3: Industry Challenges - The traditional food industry faces significant challenges, including SKU proliferation, regulatory compliance delays, and competition from agile new brands leveraging social media [7][16]. - The impact of GLP-1 drugs and extreme weather events is expected to shrink the global candy market by 15% over the next five years, adding to the uncertainty in the food sector [7][16]. Group 4: Historical Context - Nestlé's peak performance was around 2005, with revenues of approximately $74 billion, but has since faced declining growth rates and increased competition [10][14]. - The company's historical success was built on technological advancements, aggressive acquisitions, and a strong global presence, but it has struggled to adapt to the fragmented consumer landscape [15][17]. Group 5: Future Outlook - The company must transition from a traditional food model to a nutrition technology model, leveraging synthetic biology and real-time data to create personalized nutrition solutions [19][21]. - The ability to innovate and retain a connection to consumer preferences will be crucial for Nestlé to regain its competitive edge in a rapidly evolving market [8][21].

Group 1: Industry Outlook - The overall industry outlook is positive, driven by policy support and strong consumer demand, with limited impact from economic cycles on product demand [2] - There is significant growth potential in health food consumption, driven by industry upgrades, digital transformation, and functional foods [2] Group 2: Profit Growth Drivers - Key drivers for future profit growth include strengthening the supply chain, enhancing marketing efforts, and reducing costs while increasing revenue [3] - Focusing on core business and driving innovation to create new profit growth points [3] - Utilizing project development as a breakthrough to identify new economic growth opportunities [3] Group 3: Brand Operations - Implementation of brand strategy planning to enhance brand competitiveness [3] - Increased investment in product innovation to improve product competitiveness [3] - Strengthening channel development and increasing specialized personnel to achieve professional, precise, and efficient business expansion [3] Group 4: Future Development Outlook - The company's 2025 theme is to reaffirm development intentions, actively pursue reform and innovation, and strive to create a new economic development landscape [3] - Key initiatives for 2025 include focusing on core responsibilities, enhancing benchmarking, and driving innovation [3] - Leveraging the public company platform to promote mergers and acquisitions to enhance profitability [3] - Continuous innovation to improve management quality and efficiency, supporting economic development [3] - Strengthening risk prevention and compliance management to ensure economic development [3] Group 5: Financial Performance - The company has not yet released the Q1 2025 financial report, scheduled for April 29, 2025 [3]